168 related articles for article (PubMed ID: 11425917)
1. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
Wade TV; Schneider JS
J Neurosci; 2001 Jul; 21(13):4901-7. PubMed ID: 11425917
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
[TBL] [Abstract][Full Text] [Related]
3. Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.
Schneider JS; Decamp E; Wade T
J Neurosci; 1999 Aug; 19(15):6643-9. PubMed ID: 10414993
[TBL] [Abstract][Full Text] [Related]
4. Striatal preprotachykinin gene expression reflects parkinsonian signs.
Wade TV; Schneider JS
Neuroreport; 2004 Nov; 15(16):2481-4. PubMed ID: 15538179
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
[TBL] [Abstract][Full Text] [Related]
6. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Morissette M; Goulet M; Soghomonian JJ; Blanchet PJ; Calon F; Bédard PJ; Di Paolo T
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):55-62. PubMed ID: 9387863
[TBL] [Abstract][Full Text] [Related]
7. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys.
Asselin MC; Soghomonian JJ; Côté PY; Parent A
Neuroreport; 1994 Oct; 5(16):2137-40. PubMed ID: 7865763
[TBL] [Abstract][Full Text] [Related]
8. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
[TBL] [Abstract][Full Text] [Related]
10. Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA.
Zeng BY; Pearce RK; MacKenzie GM; Jenner P
Eur J Neurosci; 2000 Mar; 12(3):1096-104. PubMed ID: 10762340
[TBL] [Abstract][Full Text] [Related]
11. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates.
Soghomonian JJ; Pedneault S; Audet G; Parent A
J Neurosci; 1994 Oct; 14(10):6256-65. PubMed ID: 7931578
[TBL] [Abstract][Full Text] [Related]
12. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
13. Striatal enkephalin gene expression does not reflect parkinsonian signs.
Schroeder JA; Schneider JS
Neuroreport; 2000 Jun; 11(9):1799-802. PubMed ID: 10884022
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
[TBL] [Abstract][Full Text] [Related]
15. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Frohna PA; Rothblat DS; Joyce JN; Schneider JS
Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.
Elsworth JD; Deutch AY; Redmond DE; Taylor JR; Sladek JR; Roth RH
Neuroscience; 1989; 33(2):323-31. PubMed ID: 2622529
[TBL] [Abstract][Full Text] [Related]
17. Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.
Kulak JM; Schneider JS
Brain Res; 2004 Mar; 999(2):193-202. PubMed ID: 14759498
[TBL] [Abstract][Full Text] [Related]
18. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
[TBL] [Abstract][Full Text] [Related]
19. Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
Tel BC; Zeng BY; Cannizzaro C; Pearce RK; Rose S; Jenner P
Neuroscience; 2002; 115(4):1047-58. PubMed ID: 12453478
[TBL] [Abstract][Full Text] [Related]
20. Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms.
Dacko S; Schneider JS
Neurosci Lett; 1991 Jun; 127(1):49-52. PubMed ID: 1881617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
